A Phase 4 interventional study of massage in Shift-Work Sleep Disorder, sponsored by Taichung Veterans General Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-07-12.
Sponsored by Taichung Veterans General Hospital · Phase 4, Interventional, and Treatment
This study aims to evaluate the effects of aroma massage to sleep quality of the nurses and staff during night shift.
Night shift increases physical and psychological pressure, and even affects their sleep quality. This study aims to evaluate the effects of aroma massage to sleep quality of the nurses during night shift after life-style modification and/or aroma massage. The investigators adopt a Randomized Controlled Trial (RCT) in this study. The investigators expect aroma massage would improve the sleep quality during night shift.
788 studies on the registry are indexed under Sleep Wake Disorders; 186 are open to participants now.
This study's enrollment of 77 is above the median of 62 across 548 interventional studies indexed under Sleep Wake Disorders.
Browse Sleep Wake Disorders studies →Taichung Veterans General Hospital is the lead sponsor of 171 studies on the registry; 38 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
massage for 30 min, once a week for 4 weeks
Behavioral: massage
Rest as control
massage
brain-derived neurotrophic factor
Time frame: 4 weeks
Pittsburgh sleep quality index (PSQI)
Psychological questionnaire
Time frame: 4 weeks
Depression score ( Zung's Self-Reported Depression Scale)
Psychological questionnaire- Zung's Self-Reported Depression Scale
Time frame: 4 weeks
Anxiety score (Beck Anxiety Inventory)
Psychological questionnaire- Beck Anxiety Inventory
Time frame: 4 weeks
Heart rate variability
Cardiopulmonary functions
Time frame: 4 weeks
Metabolic syndrome (NCEP)
Third Report of the National Cholesterol Education Program (NCEP) criteria
Time frame: 4 weeks
VCAM-1
Cardiovascular risk and Inflammatory markers
Time frame: 4 weeks
Irisin
Cardiovascular risk and Inflammatory markers
Time frame: 4 weeks
circadian rhythm
orexin
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taichung Veterans General Hospital